5.79
price up icon1.22%   0.07
after-market 시간 외 거래: 5.79
loading
전일 마감가:
$5.72
열려 있는:
$5.78
하루 거래량:
4.14M
Relative Volume:
0.57
시가총액:
$1.99B
수익:
-
순이익/손실:
$-75.80M
주가수익비율:
-16.54
EPS:
-0.35
순현금흐름:
$-68.07M
1주 성능:
+3.02%
1개월 성능:
-10.37%
6개월 성능:
+149.57%
1년 성능:
+153.95%
1일 변동 폭
Value
$5.515
$5.885
1주일 범위
Value
$5.31
$6.15
52주 변동 폭
Value
$1.54
$9.75

Nuvation Bio Inc Stock (NUVB) Company Profile

Name
명칭
Nuvation Bio Inc
Name
전화
(415) 754-3517
Name
주소
357 TEHAMA STREET, FLOOR 3, SAN FRANCISCO
Name
직원
291
Name
트위터
Name
다음 수익 날짜
2025-03-05
Name
최신 SEC 제출 서류
Name
NUVB's Discussions on Twitter

Compare NUVB vs VRTX, REGN, ARGX, ALNY, ONC

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
NUVB
Nuvation Bio Inc
5.79 1.96B 0 -75.80M -68.07M -0.35
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
465.02 117.03B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
783.65 82.35B 14.34B 4.50B 3.77B 41.56
Biotechnology icon
ARGX
Argen X Se Adr
833.54 51.64B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
308.48 42.58B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ONC
Beone Medicines Ltd Adr
346.42 38.87B 4.98B 69.60M 525.67M 0.5198

Nuvation Bio Inc Stock (NUVB) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-11-24 개시 Truist Buy
2025-11-19 개시 B. Riley Securities Buy
2025-09-30 개시 Jefferies Buy
2025-04-23 개시 Citizens JMP Mkt Outperform
2024-03-27 업그레이드 Jefferies Hold → Buy
2024-03-26 업그레이드 BTIG Research Neutral → Buy
2023-01-06 다운그레이드 Jefferies Buy → Hold
2022-08-02 다운그레이드 BMO Capital Markets Outperform → Market Perform
2022-08-02 다운그레이드 BTIG Research Buy → Neutral
2022-05-04 개시 H.C. Wainwright Buy
2021-10-15 재개 BTIG Research Buy
2021-04-06 개시 RBC Capital Mkts Outperform
2021-03-08 개시 BMO Capital Markets Outperform
2021-03-08 개시 BTIG Research Buy
2021-03-08 개시 Cowen Outperform
2021-03-08 개시 Jefferies Buy
2021-03-08 개시 Wedbush Outperform
모두보기

Nuvation Bio Inc 주식(NUVB)의 최신 뉴스

pulisher
Feb 10, 2026

Forecasting The Future: 9 Analyst Projections For Nuvation Bio - Benzinga

Feb 10, 2026
pulisher
Feb 10, 2026

Nuvation Bio's (NUVB) Outperform Rating Reaffirmed at Wedbush - MarketBeat

Feb 10, 2026
pulisher
Feb 10, 2026

Nuvation Bio Announces Pivotal Global Phase 3 SIGMA Trial (G203) for Safusidenib in IDH1-Mutant Glioma - BioSpace

Feb 10, 2026
pulisher
Feb 10, 2026

Nuvation Bio expands SIGMA trial to phase 3 for IDH1-mutant glioma - Investing.com Canada

Feb 10, 2026
pulisher
Feb 09, 2026

Nuvation Bio announces pivotal global phase 3 Sigma trial (G203) for Safusidenib in IDH1-mutant glioma - marketscreener.com

Feb 09, 2026
pulisher
Feb 09, 2026

Nuvation Bio Announces Pivotal Global Phase 3 SIGMA Trial for Safusidenib in IDH1-Mutant Glioma - Investing News Network

Feb 09, 2026
pulisher
Feb 06, 2026

S P Trends: Is Nuvation Bio Inc stock undervalued right nowPrice Action & Long-Term Investment Growth Plans - baoquankhu1.vn

Feb 06, 2026
pulisher
Feb 06, 2026

Nuvation Bio Inc. (NUVB) Stock Analysis: Exploring 111.55% Potential Upside in the Biotech Sector - DirectorsTalk Interviews

Feb 06, 2026
pulisher
Feb 04, 2026

Nuvation Bio stock maintains Buy rating at B.Riley on Ibtrozi sales momentum - Investing.com Nigeria

Feb 04, 2026
pulisher
Feb 02, 2026

Analyst Endorsements Of Ibtrozi Uptake Could Be A Game Changer For Nuvation Bio (NUVB) - Sahm

Feb 02, 2026
pulisher
Feb 02, 2026

Nuvation Bio: Rollout Data Of Ibtrozi Support A Modest Buy (NYSE:NUVB) - Seeking Alpha

Feb 02, 2026
pulisher
Feb 01, 2026

Assessing Nuvation Bio (NUVB) Valuation After Bullish Analyst Calls On Ibtrozi And mIDH1 Glioma Potential - Yahoo Finance

Feb 01, 2026
pulisher
Jan 30, 2026

Turist Financial Remains a Buy on Nuvation Bio (NUVB) - Finviz

Jan 30, 2026
pulisher
Jan 30, 2026

Truist Highlights Nuvation Bio’s (NUVB) Ibtrozi’s Robust Market Uptake and Lead Over Competitors - Insider Monkey

Jan 30, 2026
pulisher
Jan 28, 2026

11 Best High Short Interest Stocks With Biggest Upside Potential - Insider Monkey

Jan 28, 2026
pulisher
Jan 28, 2026

Nuvation Bio price target raised to $13 from $11 at Truist - Yahoo Finance

Jan 28, 2026
pulisher
Jan 28, 2026

Truist Securities raises Nuvation Bio stock price target to $13 on Ibtrozi uptake - Investing.com Nigeria

Jan 28, 2026
pulisher
Jan 26, 2026

Nuvation Bio Inc. (NUVB) price target lowered as IBTROZI sales meet expectations - MSN

Jan 26, 2026
pulisher
Jan 25, 2026

Is Nuvation Bio Inc. stock undervalued right now2025 Earnings Surprises & Free AI Powered Buy and Sell Recommendations - mfd.ru

Jan 25, 2026
pulisher
Jan 25, 2026

Assessing Nuvation Bio (NUVB) Valuation After The Eisai Taletrectinib Partnership Announcement - Sahm

Jan 25, 2026
pulisher
Jan 24, 2026

JonesTrading Sticks to Their Buy Rating for Nuvation Bio (NUVB) - The Globe and Mail

Jan 24, 2026
pulisher
Jan 24, 2026

JonesTrading Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $12 - 富途资讯

Jan 24, 2026
pulisher
Jan 23, 2026

Nuvation Bio Inc. (NYSE:NUVB) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Jan 23, 2026
pulisher
Jan 23, 2026

Nuvation Bio Inc. (NUVB) Stock Analysis: 97% Potential Upside with Promising Oncology Pipeline - DirectorsTalk Interviews

Jan 23, 2026
pulisher
Jan 22, 2026

Nuvation Bio (NYSE:NUVB) Stock Price Down 4.2%Here's Why - MarketBeat

Jan 22, 2026
pulisher
Jan 21, 2026

Why Nuvation Bio (NUVB) Is Down 8.2% After Expanding Global Taletrectinib Partnership With Eisai - simplywall.st

Jan 21, 2026
pulisher
Jan 20, 2026

Nuvation Bio Inc. (NUVB) Price Target Lowered as IBTROZI Sales Meet Expectations - Yahoo Finance

Jan 20, 2026
pulisher
Jan 19, 2026

Top 10 Oncology Stocks to Buy Now - Insider Monkey

Jan 19, 2026
pulisher
Jan 19, 2026

Here’s What the Wall Street Thinks About Nuvation Bio Inc. (NUVB) - Insider Monkey

Jan 19, 2026
pulisher
Jan 18, 2026

10 Stocks Under $10 with High Potential - Insider Monkey

Jan 18, 2026
pulisher
Jan 17, 2026

Aug Closing: Whats the analyst consensus on Surrozen IncLong Setup & Fast Exit and Entry Strategy Plans - baoquankhu1.vn

Jan 17, 2026
pulisher
Jan 17, 2026

Is Nuvation Bio (NUVB) Pricing In Its Sharp Swings Or A Long Runway For Growth - Yahoo Finance

Jan 17, 2026
pulisher
Jan 16, 2026

Signal Recap: Should I invest in KORE Group Holdings Inc before earningsJuly 2025 Earnings & Fast Moving Stock Trade Plans - baoquankhu1.vn

Jan 16, 2026
pulisher
Jan 16, 2026

A Look At Nuvation Bio (NUVB) Valuation After The Eisai Taletrectinib Licensing Deal - Yahoo Finance

Jan 16, 2026
pulisher
Jan 16, 2026

A Look At Nuvation Bio’s Valuation After The Eisai Taletrectinib Collaboration Agreement - Sahm

Jan 16, 2026
pulisher
Jan 16, 2026

Is Nuvation Bio Inc stock undervalued right nowMarket Growth Report & Risk Controlled Daily Trade Plans - baoquankhu1.vn

Jan 16, 2026
pulisher
Jan 16, 2026

Eisai and Nuvation Bio ink licensing deal for taletrectinib - The Pharma Letter

Jan 16, 2026
pulisher
Jan 15, 2026

14 Best Booming Stocks to Buy Right Now - Insider Monkey

Jan 15, 2026
pulisher
Jan 15, 2026

Nuvation Bio Inc. (NUVB) Announces Exclusive Licensing Agreement With Eisai to Expand Global Reach of Taletrectinib - Insider Monkey

Jan 15, 2026
pulisher
Jan 15, 2026

Jones Trading raises Nuvation Bio stock price target to $12 on safusidenib study - Investing.com Nigeria

Jan 15, 2026
pulisher
Jan 15, 2026

Jones Trading raises Nuvation Bio stock price target to $12 on safusidenib study By Investing.com - Investing.com Australia

Jan 15, 2026

Nuvation Bio Inc (NUVB) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$44.80
price up icon 1.24%
$26.75
price down icon 0.19%
$100.75
price up icon 1.93%
$105.76
price down icon 3.31%
$146.17
price down icon 1.52%
biotechnology ONC
$346.42
price down icon 1.38%
자본화:     |  볼륨(24시간):